In the field of cancer detection, technologies to analyze tumors using biomarkers circulating
in fluids such as blood have developed rapidly based on liquid biopsy. A proactive approach …

Multiphysics microfluidics, which combines multiple functional physical processes in a
microfluidics platform, is an emerging research area that has attracted increasing interest for …

Numerous cancer-associated deaths are owing to a lack of effective diagnostic and
therapeutic approaches. Microfluidic systems for analyzing a low volume of samples offer a …

Liquid biopsy is a technology that exhibits potential to detect cancer early, monitor therapies,
and predict cancer prognosis due to its unique characteristics, including noninvasive …

Liquid biopsy for the analysis of circulating cancer biomarkers (CBs) is a major
advancement toward the early detection of cancer. In comparison to tissue biopsy …

Microfluidic separation of particles and cells is crucial to lab‐on‐a‐chip applications in the
fields of science, engineering, and industry. The continuous‐flow separation methods can …

Rapid diagnosis is an important “pillar” in the fight against breast cancer. The ultimate goal
of early detection is to find tumors before they reach a malignant stage. In recent decades, a …

Inertial microfluidics functions solely based on the fluid dynamics at relatively high flow
speed. Thus, channel geometry is the critical design parameter that contributes to the …

Microfluidic devices have led to novel biological advances through the improvement of micro
systems that can mimic and measure. Microsystems easily handle sub-microliter volumes …

Capturing rare disease‐associated biomarkers from body fluids can offer an early‐stage
diagnosis of different cancers. Circulating tumor cells (CTCs) are one of the major cancer …